SA
Sahadot Ali Mir
About Sahadot Ali Mir
Data last updated:
Sahadot Ali Mir is a Director at Alfa Biomed India Private Limited (since 2025), Director at Generic Healthcare Private Limited (since 2025) and Director at Sanzio Lifesciences Private Limited (since 2026). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is Alfa Biomed India Private Limited at ₹117 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jul 2025 | 2016 | ₹117 Cr (FY 2024) | Active | |
| Director | 23 Jul 2025 | 2010 | ₹17.92 Cr (FY 2025) | Active | |
| Director | 18 Jun 2026 | 2026 | Active |
Board colleagues of Sahadot Ali Mir
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aniket Bhalchandra Kulkarni | 09623717 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 1 more | Director |
| Anushka Abhijit Bora | 10258161 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited | Director |
| Dinesh Chandak | 09288419 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 1 more | Director |
| Kiran Sukhdeo Malekar | 09021266 | Alfa Biomed India Private Limited | Director |
| Krishna Abhijit Bora | 10830754 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 1 more | Director |
| Rohit Balkrishna Kulkarni | Alfa Biomed India Private Limited | Company Secretary | |
| Sakti Pada Chakraborty | 00064434 | Sanzio Lifesciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sahadot Ali Mir
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sahadot Ali Mir
Sahadot Ali Mir currently holds 3 directorships: Alfa Biomed India Private Limited (Director, since 23 Jul 2025, revenue ₹117 Cr (FY 2024)); Generic Healthcare Private Limited (Director, since 23 Jul 2025, revenue ₹17.92 Cr (FY 2025)); Sanzio Lifesciences Private Limited (Director, since 18 Jun 2026).
Sahadot Ali Mir was first appointed on 23 Jul 2025 as Director at Alfa Biomed India Private Limited. The most recent appointment on record is 18 Jun 2026 at Sanzio Lifesciences Private Limited.
The 2 current companies of Sahadot Ali Mir that report revenue have a combined latest revenue of ₹135 Cr: Alfa Biomed India Private Limited ₹117 Cr (FY 2024); Generic Healthcare Private Limited ₹17.92 Cr (FY 2025).
The current boards of Sahadot Ali Mir's companies include Aniket Bhalchandra Kulkarni (Alfa Biomed India Private Limited), Anushka Abhijit Bora (Alfa Biomed India Private Limited), Dinesh Chandak (Alfa Biomed India Private Limited), Kiran Sukhdeo Malekar (Alfa Biomed India Private Limited), Krishna Abhijit Bora (Alfa Biomed India Private Limited), Rohit Balkrishna Kulkarni (Alfa Biomed India Private Limited), among others.